Logo image of 1AE.DE

ARGENX SE (1AE.DE) Stock Overview

Europe - FRA:1AE - NL0010832176 - Common Stock

695 EUR
+8.4 (+1.22%)
Last: 10/9/2025, 7:00:00 PM

1AE.DE Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap42.53B
Shares61.20M
Float61.19M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)7.47
PE93.04
Fwd PE32.46
Earnings (Next)10-30 2025-10-30/bmo
IPO07-10 2014-07-10
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


1AE.DE short term performance overview.The bars show the price performance of 1AE.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

1AE.DE long term performance overview.The bars show the price performance of 1AE.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1AE.DE is 695 EUR.

ARGENX SE / 1AE Daily stock chart

1AE.DE Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 22.02 355.96B
1ABBV.MI ABBVIE INC 21.97 355.08B
AMG.DE AMGEN INC 13.58 137.77B
GIS.DE GILEAD SCIENCES INC 15.17 125.94B
VX1.DE VERTEX PHARMACEUTICALS INC 24.14 90.61B
ARGX.BR ARGENX SE 93.39 42.69B
1INSM.MI INSMED INC N/A 29.80B
22UA.DE BIONTECH SE-ADR N/A 21.76B
IDP.DE BIOGEN INC 9.18 18.63B
1EXAS.MI EXACT SCIENCES CORP N/A 9.34B
0QF.DE MODERNA INC N/A 9.26B
1MRNA.MI MODERNA INC N/A 9.25B

About 1AE.DE

Company Profile

1AE logo image argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland and currently employs 1,599 full-time employees. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.

Company Info

ARGENX SE

Laarderhoogtweg 25

Amsterdam NOORD-HOLLAND NL

Employees: 1599

1AE Company Website

1AE Investor Relations

Phone: 31763030

ARGENX SE / 1AE.DE FAQ

What is the stock price of ARGENX SE today?

The current stock price of 1AE.DE is 695 EUR. The price increased by 1.22% in the last trading session.


What is the ticker symbol for ARGENX SE stock?

The exchange symbol of ARGENX SE is 1AE and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is 1AE.DE stock listed?

1AE.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for ARGENX SE stock?

25 analysts have analysed 1AE.DE and the average price target is 736.04 EUR. This implies a price increase of 5.9% is expected in the next year compared to the current price of 695. Check the ARGENX SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ARGENX SE worth?

ARGENX SE (1AE.DE) has a market capitalization of 42.53B EUR. This makes 1AE.DE a Large Cap stock.


How many employees does ARGENX SE have?

ARGENX SE (1AE.DE) currently has 1599 employees.


Is ARGENX SE (1AE.DE) expected to grow?

The Revenue of ARGENX SE (1AE.DE) is expected to grow by 85.31% in the next year. Check the estimates tab for more information on the 1AE.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ARGENX SE (1AE.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ARGENX SE (1AE.DE) stock pay dividends?

1AE.DE does not pay a dividend.


When does ARGENX SE (1AE.DE) report earnings?

ARGENX SE (1AE.DE) will report earnings on 2025-10-30, before the market open.


What is the Price/Earnings (PE) ratio of ARGENX SE (1AE.DE)?

The PE ratio for ARGENX SE (1AE.DE) is 93.04. This is based on the reported non-GAAP earnings per share of 7.47 and the current share price of 695 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1AE.DE.


1AE.DE Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to 1AE.DE.


Chartmill TA Rating
Chartmill Setup Rating

1AE.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to 1AE.DE. 1AE.DE has an excellent financial health rating, but there are some minor concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1AE.DE Financial Highlights

Over the last trailing twelve months 1AE.DE reported a non-GAAP Earnings per Share(EPS) of 7.47. The EPS increased by 345.45% compared to the year before.


Industry RankSector Rank
PM (TTM) 41.97%
ROA 17.84%
ROE 21%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%731.11%
Sales Q2Q%102.34%
EPS 1Y (TTM)345.45%
Revenue 1Y (TTM)78.6%

1AE.DE Forecast & Estimates

25 analysts have analysed 1AE.DE and the average price target is 736.04 EUR. This implies a price increase of 5.9% is expected in the next year compared to the current price of 695.

For the next year, analysts expect an EPS growth of 805.38% and a revenue growth 85.31% for 1AE.DE


Analysts
Analysts84.8
Price Target736.04 (5.91%)
EPS Next Y805.38%
Revenue Next Year85.31%

1AE.DE Ownership

Ownership
Inst Owners41.51%
Ins Owners0.12%
Short Float %N/A
Short RatioN/A